1. Home
  2. WGS vs NGD Comparison

WGS vs NGD Comparison

Compare WGS & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • NGD
  • Stock Information
  • Founded
  • WGS 2017
  • NGD N/A
  • Country
  • WGS United States
  • NGD Canada
  • Employees
  • WGS N/A
  • NGD N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • NGD
  • Sector
  • WGS Technology
  • NGD
  • Exchange
  • WGS Nasdaq
  • NGD Nasdaq
  • Market Cap
  • WGS 2.0B
  • NGD 2.0B
  • IPO Year
  • WGS N/A
  • NGD 2004
  • Fundamental
  • Price
  • WGS $81.37
  • NGD $2.65
  • Analyst Decision
  • WGS Strong Buy
  • NGD Buy
  • Analyst Count
  • WGS 5
  • NGD 4
  • Target Price
  • WGS $67.00
  • NGD $3.04
  • AVG Volume (30 Days)
  • WGS 498.5K
  • NGD 8.0M
  • Earning Date
  • WGS 10-29-2024
  • NGD 02-11-2025
  • Dividend Yield
  • WGS N/A
  • NGD N/A
  • EPS Growth
  • WGS N/A
  • NGD N/A
  • EPS
  • WGS N/A
  • NGD 0.02
  • Revenue
  • WGS $267,228,000.00
  • NGD $861,500,000.00
  • Revenue This Year
  • WGS $43.70
  • NGD $22.53
  • Revenue Next Year
  • WGS $16.78
  • NGD $31.05
  • P/E Ratio
  • WGS N/A
  • NGD $112.53
  • Revenue Growth
  • WGS 29.41
  • NGD 14.85
  • 52 Week Low
  • WGS $1.76
  • NGD $1.09
  • 52 Week High
  • WGS $89.11
  • NGD $3.25
  • Technical
  • Relative Strength Index (RSI)
  • WGS 57.88
  • NGD 42.57
  • Support Level
  • WGS $70.69
  • NGD $2.78
  • Resistance Level
  • WGS $83.53
  • NGD $3.08
  • Average True Range (ATR)
  • WGS 5.91
  • NGD 0.11
  • MACD
  • WGS -0.16
  • NGD -0.02
  • Stochastic Oscillator
  • WGS 64.75
  • NGD 7.45

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About NGD New Gold Inc.

New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.

Share on Social Networks: